Statement Of Cash Flows [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
2021-01-01 to 2021-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Cash flows from (used in) operations before changes in working capital |
6 768
SEK
|
3 375
SEK
|
| Adjustments for decrease (increase) in trade and other receivables |
1 284
SEK
|
156,000,000
SEK
|
| Adjustments for increase (decrease) in trade and other payables |
1 007
SEK
|
247,000,000
SEK
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
509,000,000
SEK
|
464,000,000
SEK
|
| Cash flows from (used in) investing activities [abstract] | ||
| Proceeds from sales of interests in associates |
4,000,000
SEK
|
-
SEK
|
| Purchase of biological assets |
160,000,000
SEK
|
166,000,000
SEK
|
| Proceeds from sales of biological assets |
32,000,000
SEK
|
424,000,000
SEK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
1 862
SEK
|
1 741
SEK
|
| Repayments of non-current borrowings |
500,000,000
SEK
|
-
SEK
|
| Repayments of current borrowings |
261,000,000
SEK
|
411,000,000
SEK
|